Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Health's Clinical Decision Support Solutions

Molecular Health has launched two new clinical decision support solutions, Molecular Health Guide Workbench Manager and Molecular Health Guide Clinical Annotation Service. These services are based on Dataome, Molecular Health's proprietary cloud-based software platform for the automated analysis, clinical interpretation, and reporting of genetic alterations from next-generation sequencing-based tests. 

The Workbench Manager offers tools for analyzing patient's tumor data and generating custom reports. These reports cover actionable variants and summarize potentially effective and ineffective treatment options as well as treatments that may pose a higher risk of adverse reactions to patients. The software also provides a tool for matching patients to clinical trials. 

The Clinical Annotation Service enables automated delivery of clinically-reviewed annotations for actionable variants. Through the service, Molecular Health provides clinicians with clinical variant narratives, evidence-based treatment options, matching trials, and other supplemental data such as drug descriptions and drug-drug interactions. The technology can be integrated into existing workflows, pipeline management, and reporting systems for use by high-throughput laboratories and other high-volume customers.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.